Sarah L Curtis, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 111 Goose Ln Ste 1300, Guilford, CT 06437 Phone: 203-453-9192 |
Lori Lynn Ciccone, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 350 Goose Ln Ste 203b, Guilford, CT 06437 Phone: 203-932-6481 Fax: 039-324-0512 |
Emma Pellegrino, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1057 Boston Post Rd, Guilford, CT 06437 Phone: 866-389-2727 |
Brittney Ann Gunneson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 800 Boston Post Road, Guilford, CT 06437 Phone: 877-925-3637 |
Jay Raleigh Humphrey, PHYSICIAN ASSISTANT Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 652 Boston Post Rd, Guilford, CT 06437 Phone: 203-453-0677 Fax: 203-458-7015 |
Ana Rodriguez-musterer, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 385 Church St, Suite 101, Guilford, CT 06437 Phone: 203-453-0361 Fax: 203-453-8510 |
Jacqueline Schon Kegel, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 60 Ironwood Rd, Guilford, CT 06437 Phone: 203-915-3172 |
Ms. Stacy Alex Robinson, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 98 High Meadow Rd, Guilford, CT 06437 Phone: 203-927-8392 |
Michael Allegrini, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 385 Church St, Suite101, Guilford, CT 06437 Phone: 203-453-0361 Fax: 203-453-8510 |
Lauryn S Maloney-feiler, PA-C Physician Assistant - Surgical Medicare: Not Enrolled in Medicare Practice Location: 99 Kenneth Cir, Guilford, CT 06437 Phone: 203-488-2242 |
News Archive
In a new project, researchers from LIFE - the Faculty of Life Sciences at the University of Copenhagen - document that the vesicular stomatitis virus (VSV) plays a previously unknown dual role in the prevention of a number of cancers. The new findings show that the virus both kills cancer cells and stops the expression of the molecules which certain types of cancer cells produce to hide from the immune system.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that the recently-completed Phase 2 study of CXA-101, a novel cephalosporin, compared to ceftazidime for the treatment of complicated urinary tract infections (cUTI) in adults met its study objectives.
Nanoparticles from combustion engines can activate viruses that are dormant in lung tissue cells. This is the result of a study by researchers of Helmholtz Zentrum München, a partner in the German Center for Lung Research, which has now been published in the journal 'Particle and Fibre Toxicology'.
Myriad Genetics, Inc. (NASDAQ: MYGN) today announced the Journal of Cutaneous Pathology published data from a pivotal clinical validation study that showed the myPath™ Melanoma test is highly effective at differentiating benign skin moles from malignant melanoma with greater than 90 percent diagnostic accuracy. Melanoma is the most dangerous type of skin cancer and more than 76,000 new cases of melanoma are diagnosed each year in the United States.
A group of female lawmakers - including Sens. Debbie Stabenow (D-Mich.) and Lisa Murkowski (R-Alaska) and Reps. Barbara Cubin (R-Wyo.) and Lois Capps (D-Calif.) - earlier this month introduced legislation (S 573, HR 1014) that aims to improve heart disease education among women, bolster gender-specific research and increase women's access to heart disease screening, CQ HealthBeat reports.
› Verified 7 days ago